VCYT - potential rebound

NASDAQ:VCYT   Veracyte, Inc.
After a correction of more than 27% from the previous peak, it's showing a sign of rebound. Short term target at 51.43 after confirmation at 48.95.

It's good to know the advancement oft $VCYT in lung cancer detection and collaboration with $JNJ .


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.